Fund Holdings — Affinity Asset Advisors, LLC

Total Portfolio Value:
$615.08M
Total Bought:
$254.78M
Total Sold:
$179.14M
Net Transaction:
+$75.64M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Apogee Therapeutics Inc537,093592,093+55,000$15.01M$39.34M6.40%+$24.34M
Xenon Pharmaceuticals Inc.(XENE)460,000837,387+377,387$21.19M$36.05M5.86%+$14.86M
Madrigal Pharmaceuticals, Inc.(MDGL)100,000115,000+15,000$23.14M$30.71M4.99%+$7.57M
Crinetics Pharmaceuticals In447,095470,000+22,905$15.91M$22.00M3.58%+$6.09M
Autolus Therapeutics plcADS(AUTL)1,550,4083,375,000+1,824,592$9.98M$21.53M3.50%+$11.55M
Celldex Therapeutics, Inc.(CLDX)400,000510,000+110,000$15.86M$21.40M3.48%+$5.54M
Arcellx Inc
COMMON STOCK
340,000300,000-40,000$18.87M$20.86M3.39%+$2.00M
Vera Therapeutics, Inc.CL A(VERA)0470,000+470,000$0$20.27M3.29%+$20.27M
Inozyme Pharma Inc1,885,8022,642,519+756,717$8.03M$20.24M3.29%+$12.21M
Teva Pharmaceutical Industries LimitedADS(TEVA)1,900,0001,400,000-500,000$19.84M$19.75M3.21%-$82.0K
BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO)000$20.58M$18.30M2.97%-$2.28M
Kura Oncology, Inc.(KURA)191,535730,492+538,957$2.75M$15.58M2.53%+$12.83M
Spyre Therapeutics, Inc.(SYRE)517,554410,000-107,554$11.14M$15.55M2.53%+$4.41M
Verona Pharma PlcADS563,824817,833+254,009$11.21M$13.16M2.14%+$1.95M
BeOne Medicines AGADR(ONC)082,143+82,143$0$12.85M2.09%+$12.85M
Cerevel Therapeutics Hldng I750,000300,000-450,000$31.80M$12.68M2.06%-$19.12M
Nurix Therapeutics, Inc.(NRIX)690,112810,253+120,141$7.12M$11.91M1.94%+$4.79M
Astria Therapeutics Inc1,466,465845,606-620,859$11.26M$11.90M1.94%+$639.5K
Nuvalent Inc175,000150,000-25,000$12.88M$11.26M1.83%-$1.61M
Axsome Therapeutics, Inc.(AXSM)50,000139,758+89,758$3.98M$11.15M1.81%+$7.17M
Apellis Pharmaceuticals Inc
COM
75,000165,000+90,000$4.49M$9.70M1.58%+$5.21M
Alnylam Pharmaceuticals, Inc.NOTE 1 000 9 1(ALNY)000$0$9.45M1.54%+$9.45M
Centessa Pharmaceuticals PlcADS795,729830,546+34,817$6.33M$9.39M1.53%+$3.05M
Immunovant, Inc.(IMVT)345,000285,000-60,000$14.53M$9.21M1.50%-$5.33M
COMPASS Pathways plcADS(CMPS)550,0001,027,868+477,868$4.81M$8.55M1.39%+$3.74M
Inari Med Inc20,000175,000+155,000$1.30M$8.40M1.37%+$7.10M
Establishment Labs Holdings Inc.(ESTA)228,277164,589-63,688$5.91M$8.38M1.36%+$2.47M
Geron Corporation(GERN)02,500,000+2,500,000$0$8.25M1.34%+$8.25M
Morphic Hldg Inc42,670225,000+182,330$1.23M$7.92M1.29%+$6.69M
Omeros CorpNOTE 5 250 2 1000$3.60M$7.63M1.24%+$4.03M
Newamsterdam Pharma Company
ORDINARY SHARES
125,000286,200+161,200$1.40M$6.77M1.10%+$5.37M
Elevation Oncology Inc01,268,825+1,268,825$0$6.51M1.06%+$6.51M
Perspective Therapeutics, Inc.(CATX)05,100,000+5,100,000$0$6.07M0.99%+$6.07M
Absci Corporation01,025,000+1,025,000$0$5.82M0.95%+$5.82M
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$3.40M$5.78M0.94%+$2.38M
Savara Inc.(SVRA)1,150,0001,150,0000$5.41M$5.73M0.93%+$322.0K
Cytokinetics, Incorporated(CYTK)160,00080,000-80,000$13.36M$5.61M0.91%-$7.75M
Vaxcyte, Inc.(PCVX)25,00080,000+55,000$1.57M$5.46M0.89%+$3.89M
Roivant Sciences Ltd.SHS(ROIV)500,000500,0000$5.62M$5.27M0.86%-$345.0K
Fulcrum Therapeutics, Inc.(FULC)125,000550,339+425,339$843.8K$5.20M0.84%+$4.35M
Springworks Therapeutics Inc100,000100,0000$3.65M$4.92M0.80%+$1.27M
Krystal Biotech, Inc.(KRYS)25,00026,746+1,746$3.10M$4.76M0.77%+$1.66M
Mersana Therapeutics Inc1,000,0001,000,0000$2.32M$4.48M0.73%+$2.16M
Cullinan Therapeutics, Inc.(CGEM)300,000258,588-41,412$3.06M$4.41M0.72%+$1.35M
Mineralys Therapeutics, Inc.(MLYS)0327,959+327,959$0$4.23M0.69%+$4.23M
Viking Therapeutics, Inc.(VKTX)300,00050,000-250,000$5.58M$4.10M0.67%-$1.48M
Rezolute, Inc.(RZLT)01,600,000+1,600,000$0$4.08M0.66%+$4.08M
Mirum Pharmaceuticals, Inc.(MIRM)50,000160,000+110,000$1.48M$4.02M0.65%+$2.54M
MoonLake ImmunotherapeuticsCL A(MLTX)70,98875,000+4,012$4.29M$3.77M0.61%-$519.7K
Immatics N.V.SHS(IMTX)200,000350,000+150,000$2.11M$3.68M0.60%+$1.57M
Intra-Cellular Therapies Inc050,000+50,000$0$3.46M0.56%+$3.46M
Arrowhead Pharmaceuticals, Inc.(ARWR)0120,000+120,000$0$3.43M0.56%+$3.43M
Nextcure Inc01,359,037+1,359,037$0$3.03M0.49%+$3.03M
Terns Pharmaceuticals Inc66,000450,000+384,000$428.3K$2.95M0.48%+$2.52M
Protagonist Therapeutics Inc0100,000+100,000$0$2.89M0.47%+$2.89M
Helix Acquisition Corp IiCL A0250,000+250,000$0$2.59M0.42%+$2.59M
REGENXBIO Inc.(RGNX)0110,000+110,000$0$2.32M0.38%+$2.32M
Newamsterdam Pharma CompanyW EXP 11 22 202
*W EXP 99/99/999
137,000202,599+65,599$428.8K$2.24M0.36%+$1.81M
Alkermes plcSHS(ALKS)356,38475,000-281,384$9.89M$2.03M0.33%-$7.86M
Wave Life Sciences, Inc.SHS(WVE)0286,585+286,585$0$1.77M0.29%+$1.77M
Boston Scientific Corporation(BSX)025,000+25,000$0$1.71M0.28%+$1.71M
Kezar Life Sciences Inc01,761,778+1,761,778$0$1.59M0.26%+$1.59M
BridgeBio Pharma, Inc.(BBIO)80,00050,000-30,000$3.23M$1.55M0.25%-$1.68M
Arya Sciences Acqu Corp IvCL A0133,500+133,500$0$1.50M0.24%+$1.50M
Tango Therapeutics, Inc.(TNGX)300,274150,274-150,000$2.97M$1.19M0.19%-$1.78M
Zura Bio LimitedCL A(ZURA)0450,009+450,009$0$1.16M0.19%+$1.16M
Tourmaline Bio Inc68,08150,000-18,081$1.78M$1.15M0.19%-$637.4K
Travere Therapeutics, Inc.(TVTX)0125,000+125,000$0$963.8K0.16%+$963.8K
Avrobio Inc500,000700,000+200,000$680.0K$896.0K0.15%+$216.0K
Promis Neurosciences Inc265,958265,9580$305.9K$508.0K0.08%+$202.1K
Immatics N.VW EXP 07 01 202187,204187,2040$546.6K$486.7K0.08%-$59.9K
Q32 Bio Inc.(QTTB)027,777+27,777$0$473.3K0.08%+$473.3K
Context Therapeutics Inc.(CNTX)328,817328,8170$371.6K$453.8K0.07%+$82.2K
Passage Bio, Inc.(PASG)0264,266+264,266$0$356.8K0.06%+$356.8K
Avalo Therapeutics, Inc.(AVTX)010,000+10,000$0$217.5K0.04%+$217.5K
Cassava Sciences IncW EXP 11 15 202024,200+24,200$0$97.5K0.02%+$97.5K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)75,00075,0000$36.8K$22.4K0.00%-$14.3K
ADC Therapeutics SASHS(ADCT)1,013,5400-1,013,540$1.68M$0—-$1.68M
Allogene Therapeutics Inc400,0000-400,000$1.28M$0—-$1.28M
Aravive Inc346,5110-346,511$42.9K$0—-$42.9K
argenx SEADR(ARGX)7,5000-7,500$2.85M$0—-$2.85M
Ascendis Pharma A/SADR(ASND)20,0000-20,000$2.52M$0—-$2.52M
AstraZeneca PLCADR(AZN)60,0000-60,000$4.04M$0—-$4.04M
Biohaven Ltd.(BHVN)20,8660-20,866$893.1K$0—-$893.1K
Cymabay Therapeutics Inc1,090,4410-1,090,441$25.76M$0—-$25.76M
Dynavax Technologies Corp300,0000-300,000$4.19M$0—-$4.19M
EyePoint, Inc.(EYPT)109,9000-109,900$2.54M$0—-$2.54M
Immunogen Inc1,404,6080-1,404,608$41.65M$0—-$41.65M
InflaRx N.V.(IFRX)200,0970-200,097$326.2K$0—-$326.2K
Kalvista Pharmaceuticals Inc125,9690-125,969$1.54M$0—-$1.54M
LianMedicalADS(LIANY)3,779,6940-3,779,694$16.90M$0—-$16.90M
Mirati Therapeutics Inc100,0490-100,049$5.88M$0—-$5.88M
Neurocrine Biosciences, Inc.(NBIX)10,0000-10,000$1.32M$0—-$1.32M
Nuvation Bio Inc.CL A(NUVB)250,0000-250,000$377.5K$0—-$377.5K
Penumbra, Inc.(PEN)7,5000-7,500$1.89M$0—-$1.89M
Puma Biotechnology, Inc.(PBYI)202,3490-202,349$876.2K$0—-$876.2K
Relay Therapeutics, Inc.(RLAY)300,0000-300,000$3.30M$0—-$3.30M
Viridian Therapeutics, Inc.(VRDN)50,0000-50,000$1.09M$0—-$1.09M
Page 1 of 1